PERSONAL HEALTH

SMART REPORT
A comprehensive analysis of your health using
Blood, Physicals, and Health Questionnaire data

Prepared for

Virendar Singh
Basic Info Patient ID
Male /66 Yrs JPR25197

Report released on Date of Test

07/02/2025 07/02/2025
 Patient ID Date of Collection
JPR25197 07/02/25

Table of contents
Your smart report includes the following sections.

S. No. Section Page No

01 Summary for Doctors 03

02 Your Wellbeing Index 06

03 Glance of Important Parameters 07

04 Wellness Recommendations 11

05 References 12

06 Lab Report

Get personalized insights

& trends of your lab reports
Now on Tata 1mg app!

View trends & insights Scan QR to view

Disclaimer
• This is an electronically generated report and is not a • Analysis uses the attached blood test report and Well
substitute for medical advice. Being Index Questionnaire data, if present, and urine

• While following the recommendations, please be careful analysis report, if present.

of any allergies or intolerances. • Tata 1mg is not liable for any direct, indirect, special,

• If you are pregnant or lactating, some of the consequential, or other damages. This report cannot be

recommendations and analyzed information in the used for any medico-legal purposes. Partial reproduction

Smart Report may not directly apply to you. Please of the test results is not permitted. Also, TATA 1mg Labs is

consult a doctor regarding your test results and not responsible for any misinterpretation or misuse of the

recommendations. information.
 Patient ID Date of Collection
JPR25197 07/02/25

For
Doctor Summary For Virendar Singh
Good Health Gold Package with Smart Report Male /66 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/02/25 Bio. Ref. Interval Trends (For last three tests)

Complete Blood Count 28/Oct/2024 Date 2 Date 3

Hemoglobin 13.7 g/dL 13.0 - 17.0 --- --- ---

RBC 4.58 10^6/cu.mm 4.5 - 5.5 --- --- ---
HCT 45.6 % 40 - 50 --- --- ---
MCHC 30.1 g/dL 31.5 - 34.5 --- --- ---
Total Leucocyte Count 4.78 10^3/µL 4 - 10 --- --- ---
Neutrophils 60.2 % 40 - 80 --- --- ---
Lymphocytes 30.4 % 20 - 40 --- --- ---
Monocytes 5.9 % 2 - 10 --- --- ---
Eosinophils 3.5 % 1-6 --- --- ---
Basophils 0 % 0-2 --- --- ---
Absolute Basophil Count 0 10^3/µL 0.02 - 0.1 --- --- ---
Platelet Count 105 10^3/µL 150 - 410 --- --- ---

Diabetes Profile 28/Oct/2024 Date 2 Date 3

Glycosylated Hemoglobin
8.0 % 4 - 5.6 7 --- ---
(HbA1c)

Glucose - Fasting 155 mg/dL 70 - 100 --- --- ---

Kidney Function Test 28/Oct/2024 Date 2 Date 3

Creatinine 0.95 mg/dL 0.7 - 1.3 --- --- ---

Uric Acid 8.4 mg/dL 3.5 - 7.2 --- --- ---
Sodium 138 mEq/L 136 - 145 --- --- ---
Potassium 5.44 mEq/L 3.5 - 5.1 --- --- ---

Lipid Profile 28/Oct/2024 Date 2 Date 3

Cholesterol - Total 165 mg/dL <= 199.9 197 --- ---

Triglycerides 267 mg/dL 0 - 149.9 287 --- ---
Cholesterol - HDL 36 mg/dL >= 39.9 45.2 --- ---
Cholesterol - LDL 75 mg/dL 0 - 99.9 94.4 --- ---

Page 3/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Doctor Summary For Virendar Singh
Good Health Gold Package with Smart Report Male /66 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/02/25 Bio. Ref. Interval Trends (For last three tests)

Lipid Profile 28/Oct/2024 Date 2 Date 3

Cholesterol- VLDL 53 mg/dL 0 - 29.9 57.4 --- ---

Non HDL Cholesterol 128 mg/dl <= 129.9 151.8 --- ---

Liver Function Test 28/Oct/2024 Date 2 Date 3

Bilirubin - Total 0.98 mg/dL 0.2 - 1.1 --- --- ---

Protein, Total 6.40 g/dL 5.7 - 8.2 --- --- ---
Albumin 4.30 g/dL 3.2 - 4.8 --- --- ---
Aspartate Transaminase
27 U/L <= 34 --- --- ---
(SGOT)

Alanine Transaminase
34 U/L 10 - 49 --- --- ---
(SGPT)

Alkaline Phosphatase 40 U/L 45 - 116 --- --- ---

Gamma
25 U/L <= 72 --- --- ---
Glutamyltransferase (GGT)

Urine Routine & Microscopy 28/Oct/2024 Date 2 Date 3

Specific gravity 1.010 1.003 - 1.035 --- --- ---

pH 6.0 4.6 - 8 --- --- ---
Glucose Negative NEGATIVE --- --- ---
Protein Negative NEGATIVE --- --- ---
Ketones Negative NEGATIVE --- --- ---
Pus cells 1-2 /hpf 0-5 --- --- ---
Red blood cell Nil /hpf 0-2 --- --- ---
Epithelial cells 1-2 /hpf FEW --- --- ---
Casts Nil /lpf NIL --- --- ---
Crystals Nil NIL --- --- ---

Thyroid Function Test 28/Oct/2024 Date 2 Date 3

T3, Total 0.92 ng/mL 0.60 - 1.81 --- --- ---

T4, Total 6.2 µg/dl 4.5 - 12.6 --- --- ---

Page 4/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Doctor Summary For Virendar Singh
Good Health Gold Package with Smart Report Male /66 Yrs

Note This is an electronically generated summary of the attached report. It is advised to read this summary in conjunction with the
attached report and to correlate it clinically. For the trends section, the out of range values are highlighted with respect to the
bio reference range of respective reports.

Test Name Result, 07/02/25 Bio. Ref. Interval Trends (For last three tests)

Thyroid Function Test 28/Oct/2024 Date 2 Date 3

Thyroid Stimulating
5.437 uIU/ml 0.55 - 4.78 --- --- ---
Hormone - Ultra Sensitive

Page 5/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Wellbeing Index Virendar Singh
Important Findings from your Wellbeing Index Male /66 Yrs

Physicals

Height Weight Waist BMI

Data not available Data not available Data not available Data not available

Heart Age BP
Data not available Data not available

Disease Risks

Diabetes Hypertension Stroke CVD

Survey not taken yet Survey not taken yet Survey not taken yet Survey not taken yet

Depression Anxiety Stress

Survey not taken yet Survey not taken yet Survey not taken yet

* Embark on a better you by completing the wellbeing index. Here

Lifestyle Data

Habits Family History

Data not available Data not available

Page 6/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Important Parameters Virendar Singh
From your Good Health Gold Package with Smart Report Male /66 Yrs

Complete Blood Count

Gives an insight into the health of blood and blood cells which are essential to carry out various
bodily functions like transporting oxygen, fighting infections, and clotting blood after an injury.

Hemoglobin RBC HCT MCHC

13.7 g/dL 4.58 10^6/cu.mm 45.6 % 30.1 g/dL

Range: 13.0 - 17.0 Range: 4.5 - 5.5 Range: 40 - 50 Range: 31.5 - 34.5

Total Leucocyte Count Neutrophils Lymphocytes Monocytes

4.78 10^3/µL 60.2 % 30.4 % 5.9 %

Range: 4 - 10 Range: 40 - 80 Range: 20 - 40 Range: 2 - 10

Eosinophils Basophils Absolute Basophil Count Platelet Count

3.5 % 0 % 0 10^3/µL 105 10^3/µL

Range: 1 - 6 Range: 0 - 2 Range: 0.02 - 0.1 Range: 150 - 410

Diabetes Profile
Measures the level of glucose in the body and helps identify the body's ability to process glucose. It
can be used for screnning as well as monitoring the treatment of diabetes.

Glycosylated Hemoglobin (HbA1c) Glucose - Fasting

8.0 % 155 mg/dL

Range: 4 - 5.6 Range: 70 - 100

Page 7/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Important Parameters Virendar Singh
From your Good Health Gold Package with Smart Report Male /66 Yrs

Kidney Function Test

Performed to determine how well the kidneys are working. Kidneys regulate elimination of waste from
our body and maintain electrolyte balance.

Creatinine Uric Acid Sodium Potassium

0.95 mg/dL 8.4 mg/dL 138 mEq/L 5.44 mEq/L

Range: 0.7 - 1.3 Range: 3.5 - 7.2 Range: 136 - 145 Range: 3.5 - 5.1

Lipid Profile
Measures the amount of Cholesterol and Triglycerides in your blood. This gives an insight into the
health of heart and blood vessels.

Cholesterol - Total Triglycerides Cholesterol - HDL Cholesterol - LDL

165 mg/dL 267 mg/dL 36 mg/dL 75 mg/dL

Range: <= 199.9 Range: 0 - 149.9 Range: >= 39.9 Range: 0 - 99.9

Cholesterol- VLDL Non HDL Cholesterol

53 mg/dL 128 mg/dl

Range: 0 - 29.9 Range: <= 129.9

Liver Function Test

Group of blood tests commonly performed to evaluate the function of the liver which is essential to
digest food and removing toxins from the body.

Bilirubin - Total Protein, Total Albumin

0.98 mg/dL 6.40 g/dL 4.30 g/dL

Range: 0.2 - 1.1 Range: 5.7 - 8.2 Range: 3.2 - 4.8

Page 8/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Important Parameters Virendar Singh
From your Good Health Gold Package with Smart Report Male /66 Yrs

Aspartate Transaminase (SGOT) Alanine Transaminase (SGPT)

27 U/L 34 U/L

Range: <= 34 Range: 10 - 49

Alkaline Phosphatase Gamma Glutamyltransferase (GGT)

40 U/L 25 U/L

Range: 45 - 116 Range: <= 72

Urine Routine & Microscopy

Microscopic examination of urine sample to check for the presence of blood cells, crystals, bacteria,
parasites, and cells from tumors in it.

Specific gravity pH Glucose Protein

1.010 6.0 Negative Negative
Range: 1.003 - 1.035 Range: 4.6 - 8 Range: NEGATIVE Range: NEGATIVE

Ketones Pus cells Red blood cell Epithelial cells Casts

Negative 1-2 /hpf Nil /hpf 1-2 /hpf Nil /lpf

Range: NEGATIVE Range: 0 - 5 Range: 0 - 2 Range: FEW Range: NIL

Crystals
Nil
Range: NIL

Page 9/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Important Parameters Virendar Singh
From your Good Health Gold Package with Smart Report Male /66 Yrs

Thyroid Function Test

Window to the health of the butterfly shaped gland - Thyroid, which detemines how the body uses
energy.

T3, Total T4, Total

0.92 ng/mL 6.2 µg/dl

Range: 0.60 - 1.81 Range: 4.5 - 12.6

Thyroid Stimulating Hormone - Ultra Sensitive

5.437 uIU/ml

Range: 0.55 - 4.78

Page 10/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
Recommendations Virendar Singh
Male /66 Yrs
Care for better health and wellbeing

Lifestyle

Healthy Do's Don'ts

eating Eat Nutrient-Rich Fruits Listen To Your Body

And Vegetables Stop eating when you feel full and
Eat at least 100gm (1½ to 2 cups) avoid emptying your plate.
fresh fruits and 400gm (2 to 3 cups)
green leafy vegetables daily.
Nutrient-rich fruits and vegetables
prevent diseases.

Do's Don'ts Sleep

Keep The Sleep Limit Caffeine hygiene
Environment Quiet And Skip caffeine after lunch to prevent
Dark sleep disturbances caused by
Minimize noise and light exposure caffeine's long-lasting effects.
during sleep. Use white noise,
earplugs, blackout shades, or an
eye mask to promote restful sleep.

Exercise Do's

Take Stairs Start With Short Workouts

Take the stairs instead of the Start small and gradually increase
elevator. workout duration and intensity as
you get fitter.

Page 11/12
 Patient ID Date of Collection
JPR25197 07/02/25

For
References Virendar Singh
Male /66 Yrs
From trusted sources

01 Estimation of 10-year Cardiovascular Disease (CVD) Risk

D'Agostino RB Sr, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study.Circulation. 2008
Feb 12;117(6):743-53

02 Framingham Heart Study: Hypertension Risk

Parikh NI, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.Ann Intern Med.
2008;148(2):102-110.

03 Framningham Heart Study. Stroke Risk

D’Agostino RB, et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke.
1994;25(1):40-3.

04 Depression: Patient Health Questionnaire-2 (PHQ-2)

Kroenke K, et al. The Patient Health Questionnaire-2: validity of a two-item depression screener.Med Care. 2003;41(11):1284-1292.

05 Anxiety: Generalized Anxiety Disorder 2-item (GAD-2)

Kroenke K, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.Ann Intern Med.
2007;146(5):317-325.

06 Anxiety: Generalized Anxiety Disorder 7-item (GAD-7)

Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7.Arch Intern Med. 2006;166:1092-7.

07 Indian Diabetes Risk Score [IDRS]

Mohan V, et al. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India.
2005;53:759-763.

08 Dietary Guidelines for Indians

Dietary Guidelines for Indians - A Manual, Second Edition, 2011.ICMR-National Institute of Nutrition, Hyderabad.

09 My plate for the day

R. Hemalatha. Promotionof ‘My Plate for the Day’ and physical activity among the population to prevent all forms of malnutrition
and NCDs in the country, 2023.ICMR-National Institute of Nutrition, Hyderabad.

10 Healthy Eating Plate

Building a Healthy and Balanced DietThe Nutrition Source, Department of Nutrition, Harvard T.H. Chan School of Public Health.

11 Top 10 Take-Home Messages for the Primary Prevention of Cardiovascular Disease

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019 Sep 10;140(11).

12 Smoking cessation
Age-friendly Primary Health Care Centres Toolkit. World Health Organization

13 Sleep Hygiene
Irish LA, et al. The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Med Rev. 2015;22:23-36.

14 Body mass index (BMI)

Nutritional Status of Women and Men, 2019-21 India.National Family Health Survey (NFHS - 5), 2019–21.

***End of Smart Report***

Page 12/12
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074305 / 11920911 Report Date : 07/Feb/2025 10:59AM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Complete Blood Count

Hemoglobin 13.7 g/dL 13.0-17.0 Cyanide free SLS
RBC 4.58 10^6/cu.mm 4.5 - 5.5 Impedence variation
HCT 45.6 % 40 - 50 Pulse Height Average
MCV 99.4 fL 83 - 101 Calculated
MCH 29.9 pg 27 - 32 Calculated
MCHC 30.1 g/dL 31.5 - 34.5 Calculated
RDW-CV* 13.5 % 11.6-14 Calculated
Total Leucocyte Count 4.78 10^3/µL 4 - 10 Flowmetry DHSS/
Microscopy
Differential Leucocyte Count
Neutrophils 60.2 % 40-80 DHSS/ Microscopy
Lymphocytes 30.4 % 20-40 DHSS/ Microscopy
Monocytes 5.9 % 2-10 DHSS/ Microscopy
Eosinophils 3.5 % 1-6 DHSS/ Microscopy
Basophils 0 % 0-2 Flowcytometry DHSS/
Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count* 2.88 10^3/µL 2-7 Calculated
Absolute Lymphocyte Count* 1.45 10^3/µL 1-3 Calculated
Absolute Monocyte Count* 0.28 10^3/µL 0.2 - 1 Calculated
Absolute Eosinophil Count* 0.17 10^3/µL 0.02 - 0.5 Calculated
Absolute Basophil Count* 0 10^3/µL 0.02-0.1 Calculated
Platelet Count 105 10^3/µL 150 - 410 Impedence Variation
/Microscopy
MPV* 11.4 fl 6.5 - 12 Calculated
PDW* 19.7 fl 11-22 Calculated

Comment:

As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts are
additionally being reported as absolute numbers of each cell in per unit volume of blood.

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 1 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074305 / 11920911 Report Date : 07/Feb/2025 10:59AM
Referred By : Dr. Report Status : Final Report
Sample Type : Whole Blood-EDTA

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
DHSS : Double Hydrodynamic Sequential System.

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 2 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074305 / 11920911 Report Date : 07/Feb/2025 02:13PM
Referred By : Dr. Report Status : Final Report
Sample Type : WHOLE BLOOD-EDTA

HAEMATOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

HbA1c (Glycosylated Hemoglobin)

Glycosylated Hemoglobin (HbA1c) 8.0 % 4-5.6 HPLC (NGSP certified)
Estimated average glucose (eAG)* 182.90 mg/dL Calculated

Comment:
Interpretation: HbA1c%

≤5.6 Normal
5.7-6.4 At Risk For Diabetes
≥6.5 Diabetes

Adapted from American Diabetes Association.

Comments:
A 3 to 6 monthly monitoring is recommended in diabetics. People with diabetes should get the test done more often if their blood
sugar stays too high or if their healthcare provider makes any change in the treatment plan. HbA1c concentration represent the
integrated values for blood glucose over the preceding 8-12 weeks and is not affected by daily glucose fluctuation, exercise &
recent food intake.
Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy, comorbid conditions,
known CVD or advanced microvascular complications, hypoglycemia unawareness, and individual patient considerations.

Factors that interfere with HbA1c Measurement: Hemoglobin variants, elevated fetal hemoglobin (HbF) and chemically modified
derivatives of hemoglobin (e.g. carbamylated Hb in patients with renal failure) can affect the accuracy of HbA1c measurements.

Factors that affect interpretation of HbA1c Measurement: Any condition that shortens erythrocyte survival or decrease mean
erythrocyte age (e. g., recovery from acute blood loss, hemolytic anemia, HbSS, HbCC, and HbSC) will falsely lower HbA1c test
results regardless of the assay method used. Iron deficiency anemia is associated with higher HbA1c.

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered, particularly when the
HbA1c result does not correlate with the patient's blood glucose levels.

• HPLC - High performance liquid chromatography

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 3 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074306 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Fluoride Plasma F

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

FBS (Fasting Blood Sugar)

Glucose - Fasting 155 mg/dL 70-100 Hexokinase

Fasting Plasma Glucose (mg/dL) 2 hr plasma Glucose (mg/dL) Diagnosis

99 or below 139 or below Normal
100 to 125 140 to 199 Pre-Diabetes (IGT)
126 or above 200 or above Diabetes

Reference : American Diabetes Association

Comment:
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not
have it yet. A level of 126 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes.
IGT (2 hrs Post meal ), means a person has an increased risk of developing type 2 diabetes but does not have it yet. A 2-hour
glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes

Plasma Glucose Goals For people with Diabetes

Before meal 70-130 mg/dL
2 Hours after meal Less than 180 mg/dL
HbA1c Less than 7%

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 4 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Lipid Profile
Cholesterol - Total 165 mg/dL Low (desirable): < 200 CHOD-POD
mg/dL
Moderate (borderline)
200–239 mg/dL
High: >/= 240 mg/dL
Triglycerides 267 mg/dL Normal: <150, GPO
Borderline: 150 - 199,
High:200-499,
Very High>=500
Cholesterol - HDL 36 mg/dL Undesirable/high risk Accelerator Selective
<40mg/dL Detergent
Desirable/low
risk>=60mg/dl
Cholesterol - LDL 75 mg/dL Desirable: <100 Calculated
Above desirable: 100 -
129
Borderline high : 130 -
159
High : 160 - 189
Very high : >=190
Cholesterol- VLDL* 53 mg/dL <30 Calculated
Cholesterol : HDL Cholesterol* 4.5 Ratio Desirable : 3.5-4.5 Calculated
High Risk : >5
LDL : HDL Cholesterol* 2.06 Ratio Desirable : 2.5-3.0 Calculated
High risk : >3.5
Non HDL Cholesterol* 128 mg/dl Desirable:< 130, Calculated
Above Desirable:130 -
159,
Borderline High:160 -
189,
High:190 - 219,

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 5 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
Very High: >= 220

Comment:
•Lipid profile measurements in the same patient can show physiological & analytical variations. It is recommended that 3 serial
samples 1 week apart may be tested.
•Indians are at a high risk of developing atherosclerotic cardiovascular disease (ASCVD); at a much earlier age and more severe
with high mortality. Dyslipidemia (abnormal lipid profile) is the major risk factor and found in almost 80% Indians.
•Total cholesterol is the total amount of cholesterol in blood comprising of HDL, LDL-C, and VLDL.
•LDL Cholesterol (LDL-C) or “bad”cholesterol contributes most significantly to atherosclerosis leading to heart disease or
stroke and is the primary target for reducing risk for cardiovascular disease.
•High-density lipoprotein (HDL) or “good” cholesterol can lower risk of heart disease and stroke.
•Triglyceride (TG) level also plays a major role in CVD. Indians are more prone to Atherogenic dyslipidemia, a condition
associated with high TG, low HDL-C and high LDL-C; this is associated with diabetes, metabolic syndrome and insulin resistance.
Hence high triglyceride levels also need to be treated.
•Non-HDL-Cholesterol (Non-HDLC) measures all plaque forming lipoproteins (e.g. remnants, LDL-C, VLDL, Lp(a), Apo-B).
Monitoring of Non-HDLC is important in patients with high TG (e.g. diabetics, obese persons) and those already on statin
therapy.
•Lipid Association of India (LAI-2020) recommends:-

Screening of all Indians above the age of 20 years for CVD risk factors, esp. lipid profile.
Identification of Risk factors: Age (male ≥45 years, female ≥55 years); Family h/o heart disease at younger age (<55 yrs
in males, <65 yrs in female), Smoking/tobacco use, High blood pressure, Low HDL (males <40 mg/dl and females
<50mg/dl).
Fasting lipid profile is not mandatory for screening. Both fasting and non-fasting lipid profiles are equally important for
managing Indian patients.
Non-HDLC should be calculated in every subject. LAI recommends LDL-C as the primary target and Non-HDLC as the co-
primary target for initiating drug therapy.
Lifestyle modifications are of first and foremost importance for management and prevention of dyslipidemia. Among low
risk groups, treatment is started only after 3 months of lifestyle changes.
Testing for Apolipoprotein B, hsCRP, Lp(a ) should be considered for patients in moderate risk group.
Newer treatment goals based on Risk Groups and values of LDL-C and Non-HDLC

New treatment goals by Lipid Association of India (2020)

CONSIDER THERAPY (cut-off level) TREATMENT GOALS
Risk groups LDL-C (mg/dL) Non-HDLC (mg/dL) LDL-C (mg/dL) Non-HDLC (mg/dL)
<50 <80
Extreme Risk Gp Cat. A ≥50 ≥80
(Optional ≤30) (Optional ≤60)
Extreme Risk Gp Cat. B >30 >60 ≤30 ≤60
Very High Risk ≥50 ≥80 <50 <80
High Risk ≥70 ≥100 <70 <100

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 6 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
Moderate Risk ≥100 ≥130 <100 <130
Low risk ≥130* ≥160* <100 <130
*After an adequate non-pharmacological intervention for at least 3 months

•As per NCEP Expert Panel (2011) guidelines, universal screening for dyslipidemia is recommended for children between 9
- 11 yrs (repeat at 17-21 yrs). Screening is not recommended before the age of 2yrs. Above the age of 2 yrs, selective screening
is done in children with family history of premature CVD or risk factors like obesity, diabetes, and hypertension.

Note: Reference Interval as per National Cholesterol Education Program (NCEP) Report.

LIVER FUNCTION TEST

Liver Function Test
Bilirubin-Total 0.98 mg/dL 0.2 – 1.1 Vanadate oxidation
Bilirubin-Direct 0.26 mg/dL 0.0-0.3 Vanadate oxidation
Bilirubin-Indirect* 0.72 mg/dL 0.2-0.8 Calculated
Protein, Total 6.40 g/dL 5.7–8.2 Biuret
Albumin 4.30 g/dL 3.2-4.8 BCG Dye Binding
Globulin* 2.1 g/dL 2.1 - 3.9 Calculated
A/G Ratio* 2.05 Ratio 0.8 - 2.1 Calculated
Aspartate Transaminase (SGOT) 27 U/L <34 U/L Modified IFCC
SGPT (Alanine Transaminase) 34 U/L 10-49 Modified IFCC
SGOT/SGPT* 0.79 Ratio Calculated
Alkaline Phosphatase 40 U/L 46-116 IFCC Standardization
Gamma Glutamyltransferase (GGT) 25 U/L <73 Modified IFCC

Comment:

Raised ALT and AST indicate hepatocellular damage (e.g. viral or drugs etc). ALT is more liver-specific while AST is also
found in heart, skeletal muscle, and kidney. Mild elevation (less than twice normal) often resolves on its own. Fatty liver
disease (especially with metabolic syndrome) is a common cause in asymptomatic cases. Certain drugs (paracetamol,
statins), herbal supplements, energy drinks, and antibiotics may also affect liver function.
SGOT/SGPT Ratio: Typically <1 in healthy individuals (vary between 0.7-1.4; higher in women than men). High SGPT (ratio
<1) seen in acute or chronic hepatitis, autoimmune disorders, medications, toxins while ratio >1 indicates alcoholic

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 7 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
hepatitis, cirrhosis, metastasis or non-hepatic issues (hemolytic diseases, CVS disorders).
Elevated Alkaline Phosphatase and GGT: Suggest cholestatic diseases (e.g. bile duct obstruction, primary biliary
cirrhosis etc.) and can also be due to bone disease, pregnancy, chronic renal failure, malignancy, and congestive heart
failure.
High Bilirubin: Indicates jaundice due to increased RBC breakdown, liver damage (e.g., infections, toxins), or cholestasis
(e.g., gallstones, tumors).
High Protein Levels: Seen in dehydration (e.g., severe vomiting, diarrhea) or increased production (e.g., inflammation,
hematopoietic neoplasms). Low protein and albumin: Result from impaired synthesis (liver disease), decreased intake,
tissue damage, malabsorption, or increased renal excretion.

Kidney Function Test.

Blood Urea Nitrogen 13 mg/dL 9.0-23 Urease with GLDH
Urea 27.82 mg/dL 19.26-49.22 Calculated
Creatinine 0.95 mg/dL 0.7-1.3 Alkaline picrate-kinetic
Uric Acid 8.4 mg/dL 3.5-7.2 Uricase/Peroxidase
Sodium 138 mEq/L 136-145 Indirect ISE
Potassium 5.44 mEq/L 3.5-5.1 Indirect ISE
Chloride 105.0 mEq/L 98-107 Indirect ISE
BUN/Creatinine Ratio* 13.7 Ratio 12.1 - 20.1 Calculated

Comment:
BUN is directly related to protein intake and nitrogen metabolism and inversely related to the rate of excretion of urea.Blood
urea nitrogen (BUN) levels reflect the balance between the production and excretion of urea. Increased levels are seen in renal
failure (acute or chronic), urinary tract obstruction, dehydration, shock, burns, CHF, GI bleeding, nephrotoxic drugs. Decreased
levels are seen in hepatic failure, nephrotic syndrome, cachexia (low-protein and high-carbohydrate diets).
Urea is a non-proteinous nitrogen compound formed in the liver from ammonia as an end product of protein metabolism. Urea
diffuses freely into extracellular and intracellular fluid and is ultimately excreted by the kidneys. Increased levels are found in
acute renal failure, chronic glomerulonephritis, congestive heart failure, decreased renal perfusion, diabetes, excessive protein
ingestion, gastrointestinal (GI) bleeding, hyperalimentation, hypovolemia, ketoacidosis, muscle wasting from starvation,
neoplasms, pyelonephritis, shock, urinary tract obstruction, nephrotoxic drugs. Decreased levels are seen in inadequate dietary
protein, low-protein/high-carbohydrate diet, malabsorption syndromes, pregnancy, severe liver disease, certain drugs.
Creatinine is catabolic product of creatinine phosphate, which is excreted by filtration through the glomerulus and by tubular
secretion. Creatinine clearance is an acceptable clinical measure of glomerular filtration rate (GFR). Increased levels are seen in
acute/chronic renal failure, urinary tract obstruction, hypothyroidism, nephrotoxic drugs, shock, dehydration, congestive heart
failure, diabetes. Decreased levels are found in muscular dystrophy.
BUN/Creatinine ratio (normally 12:1–20:1) is decreased in acute tubular necrosis, advanced liver disease, low protein intake,

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 8 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

BIOCHEMISTRY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
and following hemodialysis. BUN/Creatinine ratio is increased in dehydration, GI bleeding, and increased catabolism.
Uric acid levels show diurnal variation. The level is usually higher in the morning and lower in the evening. Increased levels are
seen in starvation, strenuous exercise, malnutrition, or lead poisoning, gout, renal disorders, increased breakdown of body cells
in some cancers (including leukemia, lymphoma, and multiple myeloma) or cancer treatments, hemolytic anemia, sickle cell
anemia, or heart failure, pre-eclampsia, liver disease (cirrhosis), obesity, psoriasis, hypothyroidism, low blood levels of
parathyroid hormone (PTH), certain drugs, foods that are very high in purines - such as organ meats, red meats, some seafood
and beer. Decreased levels are seen in liver disease, Wilson's disease, Syndrome of inappropriate antidiuretic hormone (SIADH),
certain drugs.

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 9 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

IMMUNOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Thyroid profile Total

T3, Total 0.92 ng/mL 0.60-1.81 CLIA
T4, Total 6.2 µg/dl 4.5-12.6 CLIA
Thyroid Stimulating Hormone - Ultra 5.437 uIU/ml 0.55-4.78 CLIA
Sensitive

Comment:

Below mentioned are the guidelines for pregnancy related reference ranges for TSH, total T3 & Total T4.

Pregnancy
TSH (μIU/mL) (as per
American Thyroid Total T3 (ng/mL) Total T4(μg/dL)
Association )
1st trimester 0.1-2.5 0.81-1.90 7.33-14.8
2nd trimester 0.2-3.0 1.00-2.60 7.93-16.1
3rd trimester 0.3-3.0 1.00-2.60 6.95-15.7

TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm
.
The variation is of the order of 50%, hence time of the day has influence on the measured serum TSH concentrations.
TSH is secreted in a dual fashion: Intermittent pulses constitute 60-70% of total amount, background continuous secretion
is 30-40%.These pulses occur regularly every 1-3 hrs.
Total T3 & T4 concentrations are altered by physiological or pathological changes in thyroxine binding globulin (TBG)
capacity .
The determination of free T3 & free T4 has the advantage of being independent of changes in the concentrations and
binding properties of the binding proteins.
Changes in thyroid status are typically associated with concordant changes in T3, T4 and TSH levels.
Unexpectedly abnormal or discordant thyroid test values may be seen with some rare, but clinically significant conditions
such as central hypothyroidism, TSH-secreting pituitary tumors, thyroid hormone resistance, or the presence of
heterophilic antibodies (HAMA) or thyroid hormone autoantibodies.
For diagnostic purposes, results should be used in conjunction with other data.

TSH T3 T4 Interpretation
High Normal Normal Subclinical Hypothyroidism

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

Page 10 of 13
PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074308 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Serum

IMMUNOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
Low Normal Normal Subclinical Hyperthyroidism
High High High Secondary Hyperthyroidism
Low High/Normal High/Normal Hyperthyroidism
Non thyroidal illness / Secondary
Low Low Low Hypothyroidism

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

Page 11 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074303 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Urine

CLINICAL PATHOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method

Urine Routine & Microscopy

Urine Routine & Microscopy
Colour* Pale Yellow Pale Yellow
Appearance* Clear Clear
Specific gravity 1.010 1.003 - 1.035 pKa change
pH 6.0 4.6 - 8.0 Double Indicator
Glucose Negative Negative GOD-POD
Protein Negative Negative Protein Error Principle
Ketones Negative Negative Nitroprusside
Blood Negative Negative Peroxidase
Bilirubin Negative Negative Diazonium
Urobilinogen Normal Normal Ehrlich
Leucocyte Esterase Negative Negative Pyrrole
Nitrite Negative Negative P-arsanilic acid
Pus cells 1-2 /hpf 0-5 Microscopy
Red Blood Cells* Nil /hpf 0-2 Microscopy
Epithelial cells* 1-2 /hpf Few Microscopy
Casts* Nil /lpf Nil Microscopy
Crystals* Nil Nil Microscopy
Yeast* Nil Nil Microscopy
Bacteria* Nil Nil Microscopy

Comment:
•Note: Pre-test condition to be observed while submitting the sample-first void, mid stream urine, collected in a clean, dry, sterile
container is recommended for routine urine analysis, avoid contamination with any discharge from vaginal, urethra, perineum,
Avoid prolonged transit time & undue exposure to sunlight.
•During interpretation, points to be considered are Negative nitrite test does not exclude the urinary tract infections. Trace
proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet. False positive
reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by disinfectants, therapeutic
dyes, ascorbic acid and certain drugs.• Urine microscopy is done in centrifuged urine specimens

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 12 of 13
 PO No :PO3922273921-115

Name : Mr.VIRENDAR SINGH Client Name : TATA 1MG JAIPUR

Age/Gender : 66/Male Registration Date : 07/Feb/2025 10:38AM
Patient ID : JPR25197 Collection Date : 07/Feb/2025 07:21AM
Barcode ID/Order ID : D17074303 / 11920911 Report Date : 07/Feb/2025 12:28PM
Referred By : Dr. Report Status : Final Report
Sample Type : Urine

CLINICAL PATHOLOGY
GOOD HEALTH GOLD PACKAGE WITH SMART REPORT
Test Name Result Unit Bio. Ref. Interval Method
*** End Of Report ***
Conditions of Laboratory Testing & Reporting:
Test results released pertain to the sample, as received. Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should
be clinically correlated by the interpreting clinician. Result delays may happen because of unforeseen or uncontrollable circumstances. Test report
may vary depending on the assay method used. Test results may show inter-laboratory variations. Test results are not valid for medico-legal
purposes. Please mail your queries related to test results to Customer Care mall ID [email protected]

Disclaimer: Results relate only to the sample received. Test results marked "BOLD" indicate abnormal results i.e. higher or lower than normal. All
lab test results are subject to clinical interpretation by a qualified medical professional. This report cannot be used for any medico-legal purposes.
Partial reproduction of the test results is not permitted. Also, TATA 1mg Labs is not responsible for any misinterpretation or misuse of the
information. The test reports alone may not be conclusive of the disease/condition, hence clinical correlation is necessary. Reports should be
vetted by a qualified doctor only.

This test has been performed at

TATA 1MG JAIPUR
Address: Plot No. 16,17&18, 3rd Floor, JR
Plaza, District Shopping Center Rd, Lal Kothi,
Jaipur, Rajasthan-302015

* The parameters marked with an * are not- recognized by NABL.

Page 13 of 13
 Ensuring accuracy IN every single report
Following a 3-step review process:

Advanced systems & Experienced lab experts Each report undergoes

cutting-edge technology analyze and technicians conduct rigorous medical scrutiny & is
results with precision comprehensive reviews signed off by a doctor

Have concerns regarding the report?

Reach out to our care team at [email protected]
or chat with us
CONNECT NOW >

Accurate Testing, Assured Quality: Diagnostics Precision

Stringent quality control Cutting-edge technology Experienced lab staff

Measures meeting Robust healthcare systems 30+ medical professionals
international norms of safety equipped with calibrated & with a collective
guidelines well-maintained machinery experience of 200+ years

Verified test procedures External assessments Trained phlebotomists

Highly standardized test Thorough third-party Ensuring smooth sample
procedures following CLSI* assessment by authorized collection experience &
guidelines experts pre-analytical precision

Claim FREE doctor consultation

Watch how
Consult top doctors from
the comfort of your home
we take care of
your sample
SCHEDULE NOW>

Get Second Opinion Order Medicines EXPLORE NOW >

Explore Financial Need Help?

Book Lab Tests
Support & more 1800-102-1618

*Clinical & Laboratory Standards Institute T&C Apply

 Are you getting
enough OMEGA 3
to protect your heart?
Because 80%^ of people don’t!

Choose Tata 1mg Salmon Omega 3

for a Healthier Heart

LDL

Reduces Improves Reduces

Triglyceride Levels Good Cholesterol Inflammation

Get Optimal Requirement#

of Omega 3 in 1 Capsule

EPA DHA Fish Oil

180 mg 120 mg 1000 mg

Why Choose Us?

50% Higher Absorption+

with Triglyceride form 50% Lower
Saturated Fats*
Every batch
Tested and Certified

Upto 30% off Shop Now

^ Stark KD, et al, progress in Lipid Research 2016 | * Compared with competing products
+ Reference from NCBI published article on comparative bioavailability | # Optimal requirement of Omega-3 as mentioned by National Institutes of Health. Dietary Supplement Label Database. 2015.